Fungal infections associated with contaminated methylprednisolone injections.
Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, MI 48105, USA. ckauff@umich.edu
Carol A
CA
Kauffman
Peter G
PG
Pappas
Thomas F
TF
Patterson
D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D002555:Cerebrospinal Fluid / Q000382:microbiology; D004196:Disease Outbreaks; D004339:Drug Compounding; D004340:Drug Contamination; D016903:Drug Monitoring; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects; D016921:Meningitis, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008775:Methylprednisolone / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004718:Saccharomycetales / Q000302:isolation & purification* / Q000472:pathogenicity; D013714:Tennessee / Q000453:epidemiology; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole; D008775:Methylprednisolone